3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Breast Neoplasms
6
Malignant Solid Neoplasm
1
Inflammatory Breast Neoplasms
1
Esophageal Neoplasms
1
Carcinoma, Intraductal, Noninfiltrating
1
Breast Neoplasms, Male
1
Bladder Urothelial Carcinoma
1
Advanced Breast Carcinoma
1
Adenocarcinoma Of Esophagus
1
Interventions
Taxes
5
Paclitaxel
5
Carboplatin
4
Immunoglobulin G
2
Disulfides
2
Cisplatin
2
Bevacizumab
2
temsirolimus
1
pegfilgrastim
1
nintedanib
1
ixabepilone
1
cediranib
1
brivanib
1
Sunitinib
1
Sirolimus
1
Radiotherapy, Intensity-Modulated
1
Platinum
1
Metformin
1
Medroxyprogesterone Acetate
1
Medroxyprogesterone
1
MK 2206
1
Granulocyte Colony-Stimulating Factor
1
Gemcitabine
1
Filgrastim
1
Epothilones
1
Doxorubicin
1
Brachytherapy
1
AZD 6244
1
ALK1-Fc fusion protein, human
1
1,2-diaminocyclohexaneplatinum II citrate
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Has results
×
Endometrial Adenocarcinoma
×
Ontruzant
×
Clear all
No trials found.